Follow the DIASORIN SPA stock price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are listed on the IT market, under the authority of Consob. Operating in the Health Care sector, DIASORIN SPA has published 13 public disclosures. Market capitalisation: €3.5bn. The latest transaction was reported on 23 July 2026 (Purchase). The full history is free.
13
Insider Decl.
n/a
Thresholds
€151m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate DIASORIN SPA Hold (neutral), based on 14 analysts. Average price target: €70.45.
33Σ signal
Buys €151mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,561 of 29,064 companies
61.7
score / 100
Value
58
Quality
66
FCF yld5.5%
Earn yld4.1%
EV/EBITDA12.5x
ROE9.2%
Gross mgn65%
Net mgn13%
Debt/EBITDA2.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.